| 000 | 01848 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516210810.0 | ||
| 264 | 0 | _c20150331 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1557-9077 | ||
| 024 | 7 |
_a10.1089/thy.2013.0462 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujiwara, Kazunori | |
| 245 | 0 | 0 |
_aInfiltration of the thyroid gland by T-cell prolymphocytic leukemia. _h[electronic resource] |
| 260 |
_bThyroid : official journal of the American Thyroid Association _cAug 2014 |
||
| 300 |
_a1314-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aCladribine _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHashimoto Disease _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Prolymphocytic, T-Cell _xdrug therapy |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aLymphatic Diseases |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aNeck _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aSkin _xpathology |
| 650 | 0 | 4 | _aSplenomegaly |
| 650 | 0 | 4 |
_aThyroid Gland _xpathology |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xsecondary |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aFukuhara, Takahiro | |
| 700 | 1 | _aKitano, Hiroya | |
| 700 | 1 | _aOkazaki, Toshiro | |
| 773 | 0 |
_tThyroid : official journal of the American Thyroid Association _gvol. 24 _gno. 8 _gp. 1314-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/thy.2013.0462 _zAvailable from publisher's website |
| 999 |
_c23765404 _d23765404 |
||